Current Cancer Therapy Reviews
Title:Meet the Editor-in-Chief
Volume: 11 Issue: 1
Author(s): Kurt S. Zanker
Affiliation:
Export Options
About this article
Cite this article as:
Zanker S. Kurt, Meet the Editor-in-Chief, Current Cancer Therapy Reviews 2015; 11 (1) . https://dx.doi.org/10.2174/157339471101150706122704
DOI https://dx.doi.org/10.2174/157339471101150706122704 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Evaluation of Effect of Triterpenes and Limonoids on Cell Growth, Cell Cycle and Apoptosis in Human Tumor Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Editorial (Thematic Issue: Chemoinformatics Models for Pharmaceutical Design, Part 2)
Current Pharmaceutical Design The IGF Axis in Prostate Cancer
Current Pharmaceutical Design Meet Our Editorial Board Member:
Recent Patents on Anti-Infective Drug Discovery Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer
Current Cancer Drug Targets Application of Monoclonal Antibodies as Cancer Therapy in Solid Tumors
Current Clinical Pharmacology Neuropeptides as Autocrine Growth Factors in Cancer Cells
Current Pharmaceutical Design Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple Sclerosis
Recent Patents on CNS Drug Discovery (Discontinued) Promising Gene Therapy Using an Adenovirus Vector Carrying REIC/Dkk-3 Gene for the Treatment of Biliary Cancer
Current Gene Therapy Potential Health Benefits of Passion Fruit Peel Flour
The Natural Products Journal Terpenes and Biological Activities of Euphorbia tortilis
Letters in Organic Chemistry Molecular Determinants of Colon Cancer Susceptibility in the East and West
Current Molecular Medicine Phosphine-Gold(I) Compounds as Anticancer Agents: General Description and Mechanisms of Action
Anti-Cancer Agents in Medicinal Chemistry Current Perspectives on Anti-Aging Interventions
Letters in Drug Design & Discovery Preface [Hot Topic: Anti-Cancer Agents (Executive Editors: A.P. Kozikowski and M. Pellecchia)]
Current Pharmaceutical Design Properties of Ultraviolet Exposed Camptothecin Studied by Using Optical Spectroscopy Methods
Combinatorial Chemistry & High Throughput Screening Synthesis and Biological Activity of Pyrazolo[4,3-c]heterocyclic Derivatives: A Mini Review
Mini-Reviews in Organic Chemistry Sesbania: A Prospective Candidate to be Excavated for Anticancer Drugs
The Natural Products Journal Toxicogenomics
Current Drug Metabolism The Complexity of DEK Signaling in Cancer Progression
Current Cancer Drug Targets